Why the study?
Do DOACs improve thrombus resolution rates and times compared to warfarin in patients with postoperative DVT after orthopedic surgery?
Do DOACs improve thrombus resolution rates and times compared to warfarin in patients with postoperative DVT after orthopedic surgery?
DOACs, particularly rivaroxaban and apixaban, demonstrated superior efficacy in achieving faster and higher rates of thrombus resolution compared to warfarin for postoperative DVT in orthopedic patients.
DOACs may accelerate perioperative orthopedic VTE resolution versus warfarin; Level 5 data leaves open the need for RCTs to confirm safety and guide selection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kensuke Takeuchi (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: